Mind & Mood Archive

The vast majority of older adults would want to know if they’re in the early stages of Alzheimer’s disease and would want a blood test to learn for certain, according to a 2025 poll. Advances in testing and treatment may fuel this desire for knowledge. There are pros and cons to knowing this information. People with an early Alzheimer’s diagnosis can plan ahead, seek support, and may feel motivated to maintain their health. But the diagnosis may jeopardize their job or insurance coverage, as well as trigger anxiety or depression.

A 2025 study suggests that sleeping nine or more hours nightly is associated with worse cognitive performance, an effect that’s stronger among people with symptoms of depression.

A 2025 study suggests that women who score highly on a brain health measurement incorporating physical, lifestyle, social, and emotional factors face lower stroke odds.

A quarter of American adults live with a mental health disorder such as anxiety, depression, obsessive-compulsive disorder, or post-traumatic stress disorder. But more than half don’t seek help. Internal and external barriers may stop them from getting the care they need. Internal barriers are emotions or excuses people make to avoid treatment. External barriers include cost or difficulty finding a provider who can meet someone’s individual needs. To push past obstacles, people can investigate less-expensive mental health programs or reframe guilt-inducing thoughts.

In May 2025, the FDA approved the first blood test to detect the early stages of Alzheimer’s disease. The test looks for several proteins associated with Alzheimer’s disease. About 80% of the time, the blood test is either highly positive or highly negative, a result that’s accurate more than 90% of the time. Doctors expect that the test will soon be covered by insurance. If that happens, the test will become the standard of care for people ages 55 and older with Alzheimer’s signs or symptoms.

There are currently nine trials of vaccines for Alzheimer’s disease under way. All of them are in people with mild Alzheimer’s or with the pre-Alzheimer’s condition called mild cognitive impairment. All of the vaccines are designed to encourage the immune system to remove protein deposits from the brain. Most experimental vaccines are given by injection; one being tested at Harvard Medical School uses a nasal spray. It will be several years before we know if any of them will work.

A 2025 study suggested that getting the shingles vaccine can significantly reduce the likelihood of developing dementia, especially among women.

In a 2025 study, people with the healthiest diets and trimmest bellies at midlife had better brain connections and skills decades later, compared with people who ate the worst diets and had the most belly fat.